2.Extramammary Paget's disease due to underlying anal canal adenocarcinoma.
Shan-xian LOU ; Li-xia WANG ; Hong-qi SHI
Chinese Journal of Pathology 2006;35(11):701-701
Adenocarcinoma
;
metabolism
;
secondary
;
surgery
;
Anal Canal
;
chemistry
;
pathology
;
surgery
;
Anus Neoplasms
;
metabolism
;
pathology
;
surgery
;
Carcinoembryonic Antigen
;
analysis
;
Diagnosis, Differential
;
Humans
;
Immunohistochemistry
;
Keratin-20
;
analysis
;
Male
;
Middle Aged
;
Mucin-1
;
analysis
;
Paget Disease, Extramammary
;
metabolism
;
secretion
;
surgery
;
Skin Neoplasms
;
metabolism
;
secretion
;
surgery
3.A case of intestinal neuronal dysplasia (type B).
Shan-xian LOU ; Hong-qi SHI ; Qing-wei LIU
Chinese Journal of Pathology 2005;34(9):611-612
Autonomic Nervous System Diseases
;
metabolism
;
pathology
;
surgery
;
Colon
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Enteric Nervous System
;
abnormalities
;
pathology
;
Hirschsprung Disease
;
pathology
;
Humans
;
Infant, Newborn
;
Intestinal Diseases
;
metabolism
;
pathology
;
surgery
;
Male
;
Phosphopyruvate Hydratase
;
metabolism
;
S100 Proteins
;
metabolism
4.Chordoid meningioma in pediatric patients: a report of two cases.
Hong-qi SHI ; Shou-tian ZHU ; Shan-xian LOU
Chinese Journal of Pathology 2007;36(10):714-715
Adolescent
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Meningeal Neoplasms
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Meningioma
;
diagnostic imaging
;
metabolism
;
pathology
;
surgery
;
Mucin-1
;
metabolism
;
Tomography, X-Ray Computed
;
Vimentin
;
metabolism
5.Clear cell chondrosarcoma: report of a case.
Hong-qi SHI ; Qing-wei LIU ; Shan-xian LOU
Chinese Journal of Pathology 2007;36(7):498-499
Adult
;
Arthroplasty, Replacement, Hip
;
Bone Cysts, Aneurysmal
;
pathology
;
Bone Neoplasms
;
metabolism
;
pathology
;
surgery
;
Chondroblastoma
;
pathology
;
Chondrosarcoma
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Female
;
Femur Head
;
metabolism
;
pathology
;
surgery
;
Follow-Up Studies
;
Humans
;
Osteosarcoma
;
pathology
;
S100 Proteins
;
metabolism
6.Metabolic profile and insulin resistance in patients with OSAS
qi, SHAO ; ying, REN ; shan-kai, YIN ; hong-liang, YI
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(10):-
40/h) and non-severe group(n=15,AHI 5-40/h).Anthropometric measurements,fasting plasma glucose,insulin,blood fat,and CT quantitative measurement of abdominal adipose tissue were recorded. Results Insulin resistance index(HOMA-IR) in patients with OSAS was related to hypoxia independently of obesity variables.The severe group was characterized by more serious metabolic disorders and higher prevalence of metabolic syndrome than the non-severe group.OSAS was positively associated with an increased metabolic disorders risk for the severe group versus the non-severe group(OR=8.8).Using the receiver operating characteristic(ROC) curve analysis,waist circumference had the greatest areas under the ROC curves compared with body mass index and neck circumference.The results of multiple stepwise regression of lowest pulse oxygen saturation(LSpO2)during overnight sleep indicated that neck circumference followed by epworth sleepiness score(ESS) entered the equation(P
7.The effect of metformin on lipid disorders as measured by nuclear magnetic metabolomics and metabolic flux analysis
Qi-feng LIU ; Xue-qi LÜ ; Cong-cong GUO ; Shan-shan SUN ; Ya-nan WANG ; Xiang-ju JIN ; Ying-hong WANG
Acta Pharmaceutica Sinica 2021;56(4):1109-1119
Studies have found that metformin is not only the preferred drug for lowering blood sugar, but also shows lipid-lowering and weight-loss effects. The purpose of this study was to use a hyperlipidemia hamster model to investigate the lipid-lowering effect of metformin and its effect on important metabolic pathways in lipid metabolism disorders. Fifty golden hamsters were divided into a control group, a model group, metformin high- and low-dose groups, and a simvastatin group. A high-fat diet was fed for 1 week to create the model, and then drug was administered for 11 weeks with the high-fat diet. Serum was taken for measurement of blood lipid and blood glucose at 2, 6, and 9 weeks after administration, and at weeks 3, 5, and 9 feces and urine were collected for 1H NMR metabolomics tests. After 11 weeks of intravenous injection of [U-13C6] glucose, serum was collected for a 13C NMR metabolic flux test. The results showed that the administration of metformin can significantly reduce blood lipids and glucose levels and can significantly affect metabolic pathways such as sugar metabolism, lipid metabolism, ketone metabolism, amino acid metabolism, and intestinal flora metabolism. The results of the metabolic flux analysis showed that the high-fat diet reduced the metabolism of tricarboxylic acids by 37.48%. After administration of low and high doses of metformin the metabolism of tricarboxylic acid increased by 98.14% and 143.10%, respectively. After administration of simvastatin tricarboxylic acid metabolism increased by 33.18%. The results indicate that metformin has a significant effect on promoting energy metabolism. This study used a combination of metabolomics and metabolic flow to explore the effect of metformin on lipid metabolism disorders and quantifies changes in the key pathway of energy metabolism-the tricarboxylic acid cycle. This study provides useful information for the study of the efficacy and mechanism of metformin, as well as a practical technical method for the screening of lipid-lowering drugs based on a hamster model.
8.Signet-ring epithelioid gastrointestinal stromal tumor with rare D842Y mutation in exon 18 of PDGFRα: report of a case.
Qi SUN ; Hong-yan WU ; Xin-yan CHEN ; Jun YANG ; Qing YE ; Xiang-shan FAN
Chinese Journal of Pathology 2011;40(6):414-415
Antigens, CD34
;
metabolism
;
Carcinoma, Signet Ring Cell
;
genetics
;
metabolism
;
pathology
;
surgery
;
Codon
;
Diagnosis, Differential
;
Exons
;
Female
;
Follow-Up Studies
;
Gastrectomy
;
methods
;
Gastrointestinal Neoplasms
;
genetics
;
metabolism
;
pathology
;
surgery
;
Gastrointestinal Stromal Tumors
;
genetics
;
metabolism
;
pathology
;
surgery
;
Humans
;
Melanoma
;
metabolism
;
pathology
;
Middle Aged
;
Neurilemmoma
;
metabolism
;
pathology
;
Point Mutation
;
Proto-Oncogene Proteins c-kit
;
metabolism
;
Receptor, Platelet-Derived Growth Factor alpha
;
genetics
;
metabolism
9.Improved preparation of buffy-coat-derived platelet concentrates and factors affecting platelet recovery
Hong SHAN ; Jiaojie WANG ; Lili BIE ; Min LIU ; Zheng QI ; Yanli DUAN
Chinese Journal of Tissue Engineering Research 2014;(7):1082-1087
BACKGROUND:Buffy-coat-derived platelet concentrates and plasma-rich platelet concentrates have a high incidence of invalid infusion and adverse reactions.
OBJECTIVE:To observe the improved preparation of buffy-coat-derived platelet concentrates and to analyze the influential factors relevant to platelet recovery.
METHODS:400 mL of blood sample extracted from 126 cases were randomly divided into improved buffy-coat group, buffer-coat group and platelet-rich plasma after 4-6 hours. The 3-step centrifugal method was used for improved preparation of buffy-coat-derived platelet concentrates:step 1, centrifugation at 2 300 r/min for 12 minutes at (22±2)℃ with a deceleration of 5;step 2, centrifugation at 910 r/min for 10 minutes at (22±2)℃;step 3, centrifugation at 2 800 r/min for 12 minutes at (22±2)℃. After centrifugation, the upper layer containing few platelets was removed, and the rest 30 mL platelet suspension was platelet concentrates. Factors affecting platelet recovery were analyzed through literature retrieval.
RESULTS AND CONCLUSION:There was no difference in platelet number among the three groups before preparation of platelet concentrates (P>0.05). A higher rate of platelet recovery was found in the platelet-rich plasma group and improved buffy-coat group compared with the buffy-coat group (P<0.05), but there was no difference between the former two groups (P>0.05). There were less residual red blood cells and white blood cells in the two buffy-coat groups than the platelet-rich plasma group (P<0.05), but there was no difference between the two buffy-coat groups (P>0.05). The recovery rate of prepared platelet concentrates was affected by the whole blood amount, centrifugal speed, centrifugation time and methods. Improved buffy-coat method for preparation of platelet concentrates can be generalized in blood centers or blood stations, because it can reduce residual red blood cells and white blood cells and increase rate of platelet recovery.
10.Activation of NF-?B in airway epithelial celland modulation mechanism of NAC
Hong-Ying MO ; Nan-Shan ZHONG ; Jing-Ping ZHENG ; Qi-Cai LONG ;
Chinese Journal of Clinical Pharmacology and Therapeutics 2000;0(03):-
Aim The expression of NF-?B activation and the effect of antioxidant (N- acetylcysteine, NAC) on NF-?B activity in human airway epithelial cell was assessed. Methods Using the TNF-?,the airway epithelial cell strains of normal subject(16HBE) and tumor patient (H292) was activated and using Western-Blot and ELISA the expression of NF-?B and IL-8 were detected. Results It was found that the activity of NF-?B could be stimulated by the TNF-? and increase with the amount of TNF-? with the peak occurring at 2 to 4 hours after stimulation and then decreasing at six hours. At the same time, the level of IL-8 was elevated, but decreased with inhibition of NF-?B activity by NAC, that means the action of NAC has a dose-dependent effect. Conclusion NAC not only blocks the signal transmission activated by NF-?B, but also anticipates the transcription modulation of expression of many cell factors and inflammatory mediums. It suggests that NAC may play a role in the anti-inflammatory treatment of respiratory diseases.